{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:07:55Z","timestamp":1769011675418,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ejmech.2014.03.066","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T01:18:29Z","timestamp":1396055909000},"page":"152-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Synthesis, radiolabeling and in\u00a0vivo evaluation of [11C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT7 receptor"],"prefix":"10.1016","volume":"79","author":[{"given":"Hanne D.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2443-1174","authenticated-orcid":false,"given":"Enza","family":"Lacivita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pantaleo","family":"Di Pilato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias M.","family":"Herth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szabolcs","family":"Lehel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Ettrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valdemar L.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnete","family":"Dyssegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"De Giorgio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola Antonio","family":"Colabufo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Niso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitte M.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8401-2815","authenticated-orcid":false,"given":"Marcello","family":"Leopoldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.03.066_bib1","doi-asserted-by":"crossref","first-page":"23422","DOI":"10.1016\/S0021-9258(19)49479-9","article-title":"Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase","volume":"268","author":"Bard","year":"1993","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0896-6273(93)90149-L","article-title":"A\u00a0novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms","volume":"11","author":"Lovenberg","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2014.03.066_bib3","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1073\/pnas.90.18.8547","article-title":"Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation","volume":"90","author":"Ruat","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2014.03.066_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0748730404273432","article-title":"Circadian rhythm phenotype of 5-HT7 receptor knockout mice: 5-HT and 8-OH-DPAT-induced phase advances of SCN neuronal firing","volume":"20","author":"Sprouse","year":"2005","journal-title":"Journal of Biological Rhythms"},{"key":"10.1016\/j.ejmech.2014.03.066_bib5","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0028-3908(03)00117-5","article-title":"The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor","volume":"44","author":"Guscott","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2014.03.066_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2010.08.013","article-title":"Serotonin 5-HT7 receptor agents: structure-activity relationships and potential therapeutic applications in central nervous system disorders","volume":"129","author":"Leopoldo","year":"2011","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.ejmech.2014.03.066_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12035-011-8175-3","article-title":"Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives","volume":"43","author":"Matthys","year":"2011","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.ejmech.2014.03.066_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuropharm.2012.10.026","article-title":"The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways","volume":"67","author":"Speranza","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2014.03.066_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.biopsych.2012.06.008","article-title":"Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of fragile X syndrome","volume":"72","author":"Costa","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib10","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors","volume":"268","author":"Roth","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.ejmech.2014.03.066_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1521-8","article-title":"Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in\u00a0vivo","volume":"205","author":"Abbas","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2014.03.066_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuropharm.2013.01.023","article-title":"Effects of lurasidone in behavioral models of depression. Role of the 5-HT receptor subtype","volume":"70","author":"Cates","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2014.03.066_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.167346","article-title":"Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity","volume":"334","author":"Ishibashi","year":"2010","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.ejmech.2014.03.066_bib14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.107.119404","article-title":"Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents","volume":"321","author":"Bonaventure","year":"2007","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.ejmech.2014.03.066_bib15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.biopsych.2005.05.012","article-title":"5-HT7 receptor inhibition and inactivation induce antidepressant like behavior and sleep pattern","volume":"58","author":"Hedlund","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2006.10.001","article-title":"Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice","volume":"555","author":"Wesolowska","year":"2007","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.ejmech.2014.03.066_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuropharm.2006.04.017","article-title":"Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression","volume":"51","author":"Wesolowska","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2014.03.066_bib18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuropharm.2004.11.015","article-title":"Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression","volume":"48","author":"Guscott","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2014.03.066_bib19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tips.2006.04.004","article-title":"Using positron emission tomography to facilitate CNS drug development","volume":"27","author":"Lee","year":"2006","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.ejmech.2014.03.066_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jlcr.606","article-title":"Synthesis and preliminary PET study of the 5-HT7 receptor antagonist [11C]DR4446","volume":"45","author":"Zhang","year":"2002","journal-title":"Journal of Labelled Compounds and Radiopharmaceuticals"},{"key":"10.1016\/j.ejmech.2014.03.066_bib21","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1016\/j.bmc.2012.05.005","article-title":"Synthesis and evaluation of [(11)C]Cimbi-806 as a potential PET ligand for 5-HT(7) receptor imaging","volume":"20","author":"Herth","year":"2012","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib22","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2967\/jnumed.111.089185","article-title":"Comparison of 4 radiolabeled antagonists for serotonin 5-HT7 receptor neuroimaging: toward the first PET radiotracer","volume":"52","author":"Lemoine","year":"2011","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.ejmech.2014.03.066_bib23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2967\/jnumed.113.128983","article-title":"Radiosynthesis and in\u00a0vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors","volume":"55","author":"Hansen","year":"2014","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.ejmech.2014.03.066_bib24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1021\/jm020994z","article-title":"Synthesis and structure-affinity relationships of 1-[omega-(4-aryl-1-piperazinyl)alkyl]-1-aryl ketones as 5-HT(7) receptor ligands","volume":"46","author":"Perrone","year":"2003","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1211\/0022357022575","article-title":"Studies on 1-arylpiperazine derivatives with affinity for rat 5-HT7 and 5-HT1A receptors","volume":"56","author":"Leopoldo","year":"2004","journal-title":"Journal of Pharmacology and Pharmacotherapeutics"},{"key":"10.1016\/j.ejmech.2014.03.066_bib26","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1021\/jm049702f","article-title":"Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents","volume":"47","author":"Leopoldo","year":"2004","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib27","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1021\/jm070487n","article-title":"Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2","volume":"50","author":"Leopoldo","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib28","series-title":"The 19th International Symposium on Radiopharmaceutical Sciences, Amsterdam, NL","article-title":"Development of a PET radioligand for the 5-HT7 receptor. Preliminary characterizaion using autoradiography","author":"Andersson","year":"2011"},{"key":"10.1016\/j.ejmech.2014.03.066_bib29","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1021\/jm3003679","article-title":"Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in\u00a0vitro or ex\u00a0vivo","volume":"55","author":"Lacivita","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib30","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1021\/cn3001137","article-title":"Synthesis and in\u00a0vitro evaluation of oxindole derivatives as potential radioligands for 5-HT(7) receptor imaging with PET","volume":"3","author":"Herth","year":"2012","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.ejmech.2014.03.066_bib31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pain.2004.11.023","article-title":"Activation of 5-HT1A and 5-HT7 receptors in the parafascicular nucleus suppresses the affective reaction of rats to noxious stimulation","volume":"113","author":"Harte","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2014.03.066_bib32","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1021\/jm8014553","article-title":"Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7\/5-HT1A receptor selectivity","volume":"52","author":"Medina","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mibio.2003.09.014","article-title":"Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents","volume":"5","author":"Waterhouse","year":"2003","journal-title":"Molecular Imaging and Biology"},{"key":"10.1016\/j.ejmech.2014.03.066_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tips.2009.05.005","article-title":"PET radiotracers: crossing the blood-brain barrier and surviving metabolism","volume":"30","author":"Pike","year":"2009","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.ejmech.2014.03.066_bib35","series-title":"2-[4-(Pyrazol-4-ylalkyl)Piperazin-1-yl]-3-Phenyl Pyrazines and Pyridines and 3-[4-(Pyrazol-4-ylalkyl)piperazin-1-yl]-2-Phenyl Pyridines as 5\u2013HT7 Receptor Antagonists","author":"Badescu","year":"2008"},{"key":"10.1016\/j.ejmech.2014.03.066_bib36","first-page":"401","article-title":"Bipyridines. Part XVII. On the synthesis of [2,2'-bipyridin]-3-ol and other novel 2,2'-bipryridine derivatives from [2,2'-bipyridine]-3,3'-diamine","volume":"33","author":"Kaczmarek","year":"1985","journal-title":"Bulletin of the Polish Academy of Sciences, Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib37","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1021\/jm300403a","article-title":"Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase gamma inhibitors","volume":"55","author":"Leahy","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib38","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1021\/jm00354a002","article-title":"Ultra-short-acting beta-adrenergic receptor blocking agents. 1. (aryloxy)propanolamines containing esters in the nitrogen substituent","volume":"25","author":"Erhardt","year":"1982","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jcat.2009.08.015","article-title":"Hemicryptophane\u2013oxidovanadium(V) complexes: Lead of a new class of efficient supramolecular catalysts","volume":"267","author":"Martinez","year":"2009","journal-title":"Journal of Catalysis"},{"key":"10.1016\/j.ejmech.2014.03.066_bib40","series-title":"Substituted Piperazinyl Pyrazines and Pyridines as 5-HT7 Receptor Antagonists","author":"Cohen","year":"2009"},{"key":"10.1016\/j.ejmech.2014.03.066_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neulet.2004.06.025","article-title":"Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H]SB-269970","volume":"367","author":"Varnas","year":"2004","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.ejmech.2014.03.066_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/jcbfm.2009.190","article-title":"Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited","volume":"30","author":"Cunningham","year":"2010","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/j.ejmech.2014.03.066_bib43","series-title":"Azabicyclo [3.1.0] Hexyl Derivatives as Modulators of Dopamine D3 Receptors","author":"Bertani","year":"2007"},{"key":"10.1016\/j.ejmech.2014.03.066_bib44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.bjp.0701336","article-title":"Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b)","volume":"122","author":"Jasper","year":"1997","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.ejmech.2014.03.066_bib45","doi-asserted-by":"crossref","first-page":"14848","DOI":"10.1016\/S0021-9258(18)63778-0","article-title":"Effector coupling mechanisms of the cloned 5-HT1A receptor","volume":"264","author":"Fargin","year":"1989","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.066_bib46","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.111.088815","article-title":"11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in\u00a0vivo evaluation and drug occupancy measurements","volume":"52","author":"Ettrup","year":"2011","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.ejmech.2014.03.066_bib47","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2967\/jnumed.109.074021","article-title":"Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET","volume":"51","author":"Ettrup","year":"2010","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.ejmech.2014.03.066_bib48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jcbfm.2008.110","article-title":"Evaluation of the novel 5-HT4 receptor PET ligand [11C]SB207145 in the Gottingen minipig","volume":"29","author":"Kornum","year":"2009","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/j.ejmech.2014.03.066_bib49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.nucmedbio.2009.07.004","article-title":"A\u00a0restricted access material for rapid analysis of [(11)C]-labeled radiopharmaceuticals and their metabolites in plasma","volume":"36","author":"Gillings","year":"2009","journal-title":"Nuclear Medicine and Biology"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414002803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414002803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T06:01:54Z","timestamp":1746165714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414002803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":49,"alternative-id":["S0223523414002803"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.03.066","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, radiolabeling and in\u00a0vivo evaluation of [11C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT7 receptor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.03.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}